LRI Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

LRI Investments’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587	Sell	2 -34	-94%	-$9.64K	﹤0.01%	1503
2026 Q1	$10K	Buy	36 +22	+157%	+$6.34K	﹤0.01%	884
2025 Q4	$4.24K	Hold	14	–	–	﹤0.01%	1078
2025 Q3	$3.93K	Hold	14	–	–	﹤0.01%	1091
2025 Q2	$3.38K	Buy	14 +10	+250%	+$2.36K	﹤0.01%	1094
2025 Q1	$974	Buy	+4	New	+$1.2K	﹤0.01%	1156
2024 Q3	–	Sell	-9	Closed	-$2.46K	–	1155
2024 Q2	$2.46K	Hold	9	–	–	﹤0.01%	1026
2024 Q1	$3.11K	Buy	+9	New	+$2.96K	﹤0.01%	695

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LRI Investments's BIO Position: Q2 2026 in Review

LRI Investments reduced its Bio-Rad Laboratories Class A (BIO) stake by 94% in Q2 2026, selling an estimated $9.64K and leaving 2 shares worth $587. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

LRI Investments first reported a position in BIO in Q1 2024 and has held it in 8 quarters since. The position peaked at $10K in Q1 2026. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

LRI Investments held 2 shares of Bio-Rad Laboratories Class A worth $587 as of Q2 2026.
LRI Investments sold 34 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $9.64K.
Bio-Rad Laboratories Class A made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1503 holding.
LRI Investments first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and has held it in 8 quarters since.
LRI Investments's Bio-Rad Laboratories Class A position peaked at $10K in Q1 2026.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.